1. Patient preferences for breast cancer treatments: a discrete choice experiment in France, Ireland, Poland and Spain
- Author
-
Eugena Stamuli, Sorcha Corry, Derek Ross, Thomais Konstantopoulou, Luis Texeira, Bernard Avouac, Dominique Debiais, Liz Yates, Arni Behis, Ambrose McLoughlin, Federacja Stowarzyszeń Amazonki, Maciej Niewada, Ana Casas, and Jaime Espin
- Subjects
Adult ,Aged, 80 and over ,Cancer Research ,Adolescent ,Antineoplastic Agents ,Breast Neoplasms ,Patient Preference ,General Medicine ,Middle Aged ,Progression-Free Survival ,Decision Support Techniques ,Europe ,Young Adult ,Oncology ,Surveys and Questionnaires ,Humans ,Female ,Aged - Abstract
Aim: To understand breast cancer patients' trade-offs when choosing treatments and to identify the most important treatment attributes which drive decisions. Materials & methods: A discrete choice experiment was conducted in France, Ireland, Poland and Spain. Progression-free survival, febrile neutropenia, pain, functional well-being and out-of-pocket payment were the treatment attributes. Results: 371 patients were willing to pay €6896 per year for 1 additional year of progression-free survival, €17,288 per year for perfect functional well-being and €15,138 for one pain-free year. Patients are willing to trade off progression-free survival months for better functional abilities and less pain. Conclusion: Patient preferences should be considered by regulatory agencies, reimbursement bodies, payors and clinicians for best treatment choices for the individuals.
- Published
- 2022